Nano-X Imaging Ltd.
Nano-X Imaging Ltd is a Healthcare company operating in Medical Devices with a $112.7M market cap.
Most recent earnings call: Q4 FY25 on Apr 20, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks NNOX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NNOX.
$ curl https://api.spokenalpha.com/v1/companies/NNOXFAQ
Spoken Alpha indexes NNOX's earnings call transcripts at https://spokenalpha.com/companies/NNOX. Each call links to attributed speakers and parsed analyst Q&A. Nano-X Imaging Ltd.'s own investor relations page is at https://investors.nanox.vision/.
Nano-X Imaging Ltd. (NNOX) held its most recent earnings call on 2026-04-20, covering fiscal Q4 2025.
Nano-X Imaging Ltd. (NNOX) operates in the Healthcare sector (Medical Devices industry).
Repeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $0.76 | $1.08 | -29.2% | +6.3% | +9.0% |
| Q4 FY2025 | $0.86 | $1.09 | -21.5% | +8.1% | +8.3% |
| Q3 FY2025 | $1.04 | $1.30 | -19.9% | -1.6% | -1.7% |
| Q2 FY2025 | $0.93 | $1.20 | -22.7% | +1.6% | +0.1% |
| Q1 FY2024 | $0.85 | $1.12 | -24.3% | +6.5% | +8.5% |
| Q4 FY2024 |
| $0.91 |
| $1.17 |
| -22.5% |
| +0.6% |
| -0.4% |
| Q3 FY2024 | $0.82 | $1.16 | -29.3% | +7.3% | +8.7% |
| Q2 FY2024 | $0.93 | $1.26 | -25.9% | -0.9% | -3.7% |
| Q1 FY2023 | $0.93 | $1.25 | -25.6% | +5.1% | +7.5% |
| Q4 FY2023 | $0.95 | $1.26 | -24.4% | +7.0% | +5.2% |